Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | polymerase (DNA directed), eta | Starlite/ChEMBL | No references |
Homo sapiens | glucagon-like peptide 1 receptor | Starlite/ChEMBL | No references |
Influenza A virus | Nonstructural protein 1 | Starlite/ChEMBL | No references |
Homo sapiens | chromobox homolog 1 | Starlite/ChEMBL | No references |
Mus musculus | RAR-related orphan receptor gamma | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Mycobacterium tuberculosis | Hypothetical protein | Nonstructural protein 1 | 230 aa | 202 aa | 23.8 % |
Loa Loa (eye worm) | pigment dispersing factor receptor c | glucagon-like peptide 1 receptor | 463 aa | 388 aa | 25.8 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | dna polymerase eta | 0.0054 | 0.538 | 0.538 |
Schistosoma mansoni | terminal deoxycytidyl transferase | 0.0023 | 0.0654 | 0.0654 |
Schistosoma mansoni | DNA polymerase eta | 0.0054 | 0.538 | 0.538 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.006 | 0.6323 | 0.6323 |
Mycobacterium tuberculosis | Conserved hypothetical protein | 0.0023 | 0.0654 | 0.5 |
Mycobacterium ulcerans | DNA polymerase IV | 0.0023 | 0.0654 | 0.5 |
Entamoeba histolytica | deoxycytidyl transferase, putative | 0.0023 | 0.0654 | 0.5 |
Echinococcus granulosus | dna polymerase kappa | 0.0023 | 0.0654 | 0.0654 |
Trichomonas vaginalis | chromobox protein, putative | 0.0084 | 1 | 1 |
Trypanosoma cruzi | DNA polymerase eta, putative | 0.0038 | 0.2911 | 0.4775 |
Leishmania major | DNA polymerase eta, putative | 0.0054 | 0.538 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0037 | 0.2754 | 0.2754 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0033 | 0.2204 | 0.1658 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.006 | 0.6323 | 0.6323 |
Mycobacterium ulcerans | DNA polymerase IV | 0.0023 | 0.0654 | 0.5 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0041 | 0.3396 | 0.3396 |
Onchocerca volvulus | Heterochromatin protein 1 homolog | 0.0051 | 0.487 | 1 |
Echinococcus granulosus | chromobox protein 1 | 0.0084 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0033 | 0.2204 | 0.1658 |
Echinococcus multilocularis | chromobox protein 1 | 0.0084 | 1 | 1 |
Schistosoma mansoni | chromobox protein | 0.0084 | 1 | 1 |
Trypanosoma cruzi | DNA polymerase eta, putative | 0.0054 | 0.538 | 1 |
Loa Loa (eye worm) | heterochromatin protein 1 | 0.0084 | 1 | 1 |
Echinococcus granulosus | chromobox protein 1 | 0.0084 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0041 | 0.3396 | 0.3396 |
Trypanosoma brucei | DNA polymerase eta, putative | 0.0054 | 0.538 | 1 |
Onchocerca volvulus | Heterochromatin protein 1 homolog | 0.0047 | 0.4319 | 0.7399 |
Brugia malayi | ImpB/MucB/SamB family protein | 0.0054 | 0.538 | 0.538 |
Trichomonas vaginalis | chromobox protein, putative | 0.0051 | 0.487 | 0.4511 |
Giardia lamblia | DINP protein human, muc B family | 0.0023 | 0.0654 | 0.5 |
Leishmania major | DNA polymerase eta, putative | 0.0038 | 0.2911 | 0.4775 |
Echinococcus multilocularis | chromobox protein 1 | 0.0084 | 1 | 1 |
Brugia malayi | ImpB/MucB/SamB family protein | 0.0023 | 0.0654 | 0.0654 |
Schistosoma mansoni | hypothetical protein | 0.0041 | 0.3396 | 0.3396 |
Loa Loa (eye worm) | ImpB/MucB/SamB family protein | 0.0023 | 0.0654 | 0.0654 |
Trichomonas vaginalis | chromobox protein, putative | 0.0084 | 1 | 1 |
Brugia malayi | chromobox protein homolog 3 | 0.0047 | 0.4319 | 0.4319 |
Schistosoma mansoni | rab geranylgeranyl transferase alpha subunit | 0.0023 | 0.0654 | 0.0654 |
Loa Loa (eye worm) | hypothetical protein | 0.0054 | 0.538 | 0.538 |
Toxoplasma gondii | ImpB/MucB/SamB family protein | 0.0038 | 0.2911 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0047 | 0.4319 | 0.3922 |
Loa Loa (eye worm) | hypothetical protein | 0.0047 | 0.4319 | 0.4319 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.006 | 0.6323 | 0.6323 |
Echinococcus multilocularis | terminal deoxycytidyl transferase rev1 | 0.0023 | 0.0654 | 0.0654 |
Trichomonas vaginalis | chromobox protein, putative | 0.0051 | 0.487 | 0.4511 |
Loa Loa (eye worm) | hypothetical protein | 0.006 | 0.6323 | 0.6323 |
Echinococcus multilocularis | dna polymerase kappa | 0.0023 | 0.0654 | 0.0654 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0047 | 0.4319 | 0.3922 |
Echinococcus granulosus | terminal deoxycytidyl transferase rev1 | 0.0023 | 0.0654 | 0.0654 |
Echinococcus multilocularis | dna polymerase eta | 0.0054 | 0.538 | 0.538 |
Mycobacterium tuberculosis | Possible DNA-damage-inducible protein P DinP (DNA polymerase V) (pol IV 2) (DNA nucleotidyltransferase (DNA-directed)) | 0.0023 | 0.0654 | 0.5 |
Schistosoma mansoni | chromobox protein | 0.0084 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 2.5119 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b: Cytotox Counterscreen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588855, AID588860] | ChEMBL. | No reference |
Potency (functional) | 4.1475 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | = 4.4668 um | PUBCHEM_BIOASSAY: qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 10 uM | PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962] | ChEMBL. | No reference |
Potency (functional) | 10 uM | PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 11.6891 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 15.8489 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Eta. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588636] | ChEMBL. | No reference |
Potency (functional) | = 19.9526 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Influenza NS1 Protein Function. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 20.5962 uM | PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648] | ChEMBL. | No reference |
Potency (functional) | 22.3872 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of binding or entry into cells for Lassa Virus. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249] | ChEMBL. | No reference |
Potency (functional) | = 25.1189 um | PUBCHEM_BIOASSAY: Counterscreen qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization. This assay monitors tau fibrillation by fluorescence polarization (FP) of Alexa 594-labeled K18 P301L, which does not fibrillize readily but incorporates into growing filaments of unlabeled tau. (Class of assay: confirmatory) [Related pubchem assays: 596 ] | ChEMBL. | No reference |
Potency (functional) | 28.1838 uM | PubChem BioAssay. qHTS for Activators of Integrin-Mediated Alleviation for Muscular Dystrophy. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 28.1838 uM | PubChem BioAssay. qHTS for Antagonist of cAMP-regulated guanine nucleotide exchange factor 3 (EPAC1): primary screen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 35.4813 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 35.4813 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860] | ChEMBL. | No reference |
Potency (functional) | = 37.6505 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))] | ChEMBL. | No reference |
Potency (binding) | = 39.8107 um | PUBCHEM_BIOASSAY: qHTS Assay for Identification of Novel General Anesthetics. In this assay, a GABAergic mimetic model system, apoferritin and a profluorescent 1-aminoanthracene ligand (1-AMA), was used to construct a competitive binding assay for identification of novel general anesthetics (Class of assay: confirmatory) [Related pubchem assays: 2385 (Probe Development Summary for Identification of Novel General Anesthetics), 2323 (Validation apoferritin assay run on SigmaAldrich LOPAC1280 collection)] | ChEMBL. | No reference |
Potency (functional) | 50.1187 uM | PubChem BioAssay. qHTS of PTHR Inhibitors: Primary Screen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 79.4328 uM | PubChem BioAssay. qHTS for Antagonist of cAMP-regulated guanine nucleotide exchange factor 2 (EPAC2): primary screen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Homo sapiens | ChEMBL23 | ||
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.